19-Aug-2019: The global clinical trial
imaging market size is expected to reach USD 1.31
billion by 2026, according to a new report by Grand View Research, Inc.,
progressing at a CAGR of 5.8% during the forecast period. Increasing spending
on research and development activities to develop new drugs and therapies to
treat chronic diseases is boosting market growth.
Clinical trials
assist in the development, registration, and eventually access of new drugs to
patients. Imaging helps in the process of drug development by offering
non-invasive evaluation of drug action and response of tumor to treatment.
Functional imaging techniques are progressively being used in early phases of
clinical trials to study initial effects of drug action on parts of tumor
biology including metabolism, cellularity, and vascularity.
Contract Research
Organizations (CROs) were the most prominent end-use segment in the market in
2017. Imaging modalities are used to determine indicators of pharmacological
response to a therapy. Biomarkers and surrogate endpoints assist in obtaining
quick results with good statistical power even in small sample sizes
encouraging CROs to carryout multiple studies with reduced cost of operation.
The market in Asia
Pacific is projected to witness swift growth during the forecast period as the
number of CROs and pharmaceutical organizations in the region are increasing in
recent past due to low cost of labor and public and private funding offered in
countries such as India and China. However, inaccessibility of trial protocols
and poor quality of registered clinical trial data, results, and
participant-level data undermined the potential benefits of clinical trial
registration earlier. Nevertheless, emergence of national and regional
registries and ICTRP have facilitated to overcome aforementioned barriers in
APAC.
In
depth research report on Clinical Trial Imaging Market
Further key findings from the report suggest
·
North America dominated the market in 2017. Attaining
compliance with registration requires a combination of international and local
measures and remains a key challenge in many countries. However, U.S. FDA and
other regulatory organizations have played a leading role in attaining
accomplishments of trial registration to date and is likely to be supported in
tackling such challenges in the near future
·
Some of the players operating in this market are Parexel
International Corporation; Intrinsic Imaging; Radiant Sage; Icon PLC; Worldcare
Clinical; Bioclinica Inc.; Navitas Life Sciences; Resonance Health; Ixico PLC;
and Medpace.
Grand View Research
has segmented the global clinical trial imaging market based on service,
modalities, end-use, and region:
Clinical Trial Imaging Service Outlook (Revenue, USD Million,
2014 - 2026)
·
Clinical trial design and consultation services
·
Reading and analytical Services
·
Operational Imaging services
·
System and technology support services
·
Project and Data Management
Clinical Trial Imaging Modalities Outlook (Revenue, USD
Million, 2014 - 2026)
·
Computed Tomography (CT) Scan
·
MRI ( Magnetic Resonance Imaging)
·
X-Ray
·
Ultrasound
·
Optical Coherence Tomography (OCT)
Others (Positron
Emission Tomography (PET), Single-Photon Emission Computerized Tomography
(SPECT)Reading and analytical Services
Clinical Trial Imaging End-use Outlook (Revenue, USD Million,
2014 - 2026)
·
Biotechnology and Pharmaceutical companies
·
Medical Devices Manufacturers
·
Academic and government research institutes
·
Contract Research Organization (CROs)
·
Others (Cosmetics and skin care industries)
Browse
more research reports of this category:
About
Grand View Research
Grand View Research, Inc. is a U.S.
based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides syndicated
research reports, customized research reports, and consulting services. To help
clients make informed business decisions, the company offers market
intelligence studies ensuring relevant and fact-based research across a range
of industries including technology, chemicals, materials, healthcare and
energy.
No comments:
Post a Comment